INTRODUCTION
Prostaglandins (PGs) are lipid compounds that participate in a variety of physiologic and pathologic processes, and among them, PGE 2 is a major mediator for inflammation.
[1] PGE 2 is formed by PG synthetase from PGH 2 through the cyclooxygenase (COX) pathway. Two types of COX have been identified: (i) COX-1 has been expressed constitutively in various tissues, including stomach, and (ii) COX-2 has been induced by cytokines, growth factors, tumor promoters, and other agents. [2] Newly synthesized PGE 2 simply diffused and actively extruded by the multidrug resistance 4 (MRP4) from the cells. [3] Subsequently, EPR receptor is activated followed by pericellular PGE 2 is cleared via re-uptake of PGE 2 by PG transporter (PGT) [4] and then rapidly metabolized by cytosolic enzyme named NAD + -dependent 15-hydroxyprostaglandin dehydrogenase . [5] This enzyme is expressed ubiquitously in mammalian tissues and responsible for biologic inactivation of PGE 2 to 15-ketoprostaglandins. [6] PGE 2 has been known as an important mediator for bone formation, [7, 8] gastric ulcer healing, [9, 10] and dermal wound healing. [11, 12] Additionally, PGE 2 has been used to treat gastric ulcer in spite of high price and low efficacy. [13, 14] Therefore, PGE 2 elevation using 15-PGDH inhibitor would be valuable for the management disease that required elevated PGE 2 , like wound healing. Wound healing is a complicated process in human or animal in which skin or another organ-tissue repair itself after having wound. [15] In normal skin, epidermis and dermis maintain steadystate equilibrium to maintain protective barrier against the external environment. Once the protective barrier is broken, the wound-healing process immediately set in motion and complex biochemical events takes place to repair the damage. [16] The aim of this study was to screen most potent 15-PGDH inhibitor from plant source and evaluate its woundhealing efficacy using in-vitro scratch model in HaCaT cell.
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from Sigma (St. Louis, MO, USA). TGF-β1 was purchased from BioVision (California, USA) and pGEX-2T expression vector from Pharmacia Crop. (New Jersey, USA). cDNA of human 15-PGDH was cloned from human placenta as illustrate earlier. [17] PGE 2 enzyme immunoassay kits were obtained from Thermo Scientific (Rockford, IL, USA). UV-Vis spectrophotometer (Shimadzu, Japan) was used to obtain UV spectra. Real-time PCR was performed using a Light Cycler 2.0 (Roche, Mannheim, Germany). Scratches were visualized and pictures captured using a transmission electron microscope (Hitachi, Tokyo, Japan).
Sample preparation
Different parts of plants were dried in the dark for 7 days and then grounded to powder. The powder samples were extracted three times with ethanol and extracts were obtained through removal of solvents during evaporations. The concentrated samples were stored at -20°C. One hundred milligram of crude extracts were dissolved in 1 ml of commercial grade ethanol.
Expression and purification of 15-PGDH pGEX-2T expression vector was used to transform 15-PGDH cDNA plasmid into E. coli BL-21 lysS. The cells were grown in LB Broth (1.0 L) containing 50 mg/L ampicillin at 37°C and 230 × g. Isopropyl-1-thio-β-d-galactopyranoside was added to 1 mM when OD 600 reached 0.8 and cells were allowed to grow for additional 12 h at 25°C. Cells were harvested by centrifugation at 4000g for 20 min at 4°C and pellets were resuspended in 20 mL of cold cell lysis buffer (1× PBS buffer pH 7.4 containing 1 mM EDTA and 0.1 mM DTT) and sonicated (3 × 15 s at 4°C) to disrupt cells. Sonicated pallets were centrifuged at 4000g for 20 min at 4°C and supernatant obtained was applied to a glutathione-sepharose 4B column. The column was rinsed with lysis buffer until OD 280 reach less than 0.002. 15-PGDH was eluted from column using elution buffer (50 mM Tris-HCl pH 8.0 containing 10 mM reduced glutathione, 1 mM EDTA, and 0.1 mM DTT). The purity of 15-PGDH was examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and concentration measured.
15-PGDH assay
The inhibitory activity was evaluated using fluorescence spectrophotometer, measuring formation of NADH at 468 nm following excitation at 340 nm. Reaction mixture was prepared in 2 mL of TrisHCl buffer (50 mM, pH 7.5) containing 0.1 mM DTT, 0.25 mM NAD + , purified enzyme (10 µg), 21 µM PGE 2 and various concentration inhibitors. 15-PGDH inhibitory activities were evaluated using standard curve of NADH. Each concentration of inhibitor was assayed in triplicate.
Cell culture, cell viability assay, and determination of PGE 2 release
HaCaT cell line (Keratinocyte cells) was cultured in Dulbecco's modified Eagle's media (DMEM) supplemented with 10% heat inactivated fetal bovine serum (Sigma) and 100 µg/mL penicillin. Cells were cultured in a 5% CO 2 atmosphere at 37°C. Cell viabilities were evaluated using MTT assay. [18] HaCaT cells (1 × 10 4 /90 μL of DMEM medium) were seeded in 96-well plates. After overnight incubation, plant extract samples were treated for 72 h and after that 10 µL of MTT (5 mg/mL stock solution) was added into each well, incubated for 4 h at 5% CO 2 atmosphere at 37°C. Medium was then removed and 150 μL of DMSO was added to dissolve Formazan crystals. Absorbance was measured at 540 nm using ELISA microplate reader (Perkin-Elmer, California, USA). Extracellular PGE 2 releases were determined in HaCaT cell line using various concentrations of five most potent plant extracts as a 15-PGDH inhibitor. HaCaT cells were seeded (5 × 10 5 cells/well) into six-well culture plates in DMEM, supplemented with fetal bovine serum and antibiotics for overnight under 5% CO 2 , 37°C. Various concentrations of plant extract were added into individual well and media collected after 6 h for extracellular determination and cells were harvested for intracellular determination of PGE 2 . Concentrations of PGE 2 were determined using PGE 2 enzyme immunoassay kit (Cayman, MI, USA).
Quantitative real-time PCR
Total cellular RNA was isolated from HaCaT cells according to TRI reagent-specific instruction (RNA iso Plus, Takara Bio. Inc., Shiga, Japan). cDNA was synthesized using reagent-specific instruction of Superscript First Strand synthesis system for reverse transcription-PCR (Invitrogen, Carlsbad, CA, USA) from isolated RNAs. Primers used for real-time PCR were as follows: COX-1 forward, 5'-CCTCAT GTTTGCCTTCTTTGC-3' and reverse, 5'-GGC GGGTACATTTCTCCATC-3' COX-2 forward, 5'-GATCTA CCCTCCTCAA-3' and reverse, 5'-GAACAACTGC TCATCAC-3' MRP4 forward, 5'-AACCTCTAACCGACATTCCTG-3' and reverse, 5'-TCAACATA TTACAGCCACCATC-3' human PGT forward, 5'-GGATGCTGTTTGGAGGAATCCTCA-3' and reverse, 5'-GCACGATCCTGTC TTTGCTGAA-3' and β-actin forward, 5'-GACTATGACTTAGTTGCGTTA-3' and reverse, 5'-GTTGAACTCTCTACATAC TTCCG-3' . PCR reaction mixture contained 4 µL of diluted cDNA (1:5), 10 pmole of each forward and reverse primer, 4 mM MgCl 2 , and 4 µL of Fast Starter Mix buffer (dNTPs, SYBR Green dye and Tag polymerase).
In-vitro wound healing
In-vitro scratch assay was performed in HaCaT cell line to examine wound-healing effect as previously reported [19, 20] using EEAH. HaCaT cells were seeded into six-well plates (5 × 10 5 cells per well) and grown until reached to 80% confluence. After that media was replaced with serumfree DMEM containing mitomycin (10µg/mL) and cells were incubated for 2 h to prevent wound proliferation. Plates were extensively washed with PBS and then scratches were made using sterile 200 μL pipette tip, and cells were re-washed. TGF-β1 (100 pg/mL) as a positive control or EEAH were added to the medium. Pictures were taken in the same position before and after incubation to document the wound-healing process. Scratch experiments were repeated thrice and representative pictures are included in this study. Scratches were photographed under microscope (×100) immediately after scratching and also after 48 h of incubation at 37°C in 5% CO 2 incubator.
Statistical analysis
Each experiment was performed at least three times and data are expressed as mean ± SE. Statistical significance was determined using paired Student's t-test and P value less than 0.05 were considered statistically significant. 
RESULTS
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DISCUSSION
Plant as a source of medicine used for traditional healthcare system for several thousands of years. [21] New drug development scientists have been focusing their studies on medicinal plants in different parts of the world. [22, 23] There are significant economic benefits in the development of new medicines from plants for the treatment of various diseases. [24] Twenty-five percent of medicines belong to plants source and their derivatives. [25] Plants as a source of traditional medicine are used to cure diseases involving skin problems, cold, fever, cough, headache, diarrhea, fertility problems, and toothache. [26] Therefore, 15-PGDH inhibitor was investigated in this study because of diverse therapeutic values and ample of opportunity to develop new drug from plant source. 15-PGDH negatively regulates PGE 2 levels and activity in vivo. [27, 28] In this study, extracellular and intracellular PGE 2 levels were elevated in HaCaT cell line after treatment of 15-PGDH inhibitors Table 1 and 15-PGDH inhibition and percentage increment in PGE 2 were measured using ELISA kit. They increased PGE 2 in a concentration-dependent manner and EEAH increased PGE 2 level significantly [ Table 1 ]. Results confirmed that tested inhibitors increased PGE 2 level in vitro cellular system. Further investigation was concentrated on EEAH.
Regulation of COX-1/2, PGT, and MRP4 by EEAH PGE 2 level in cellular system might depend on the expression level of COX-1/2, MRP4, and PGT. COX-1/2 is responsible for the production of PGE 2 from PGH 2 and MRP4 and PGT plays important role in the transportation of PGE 2 . Relatively low concentration of extracellular PGE 2 compared with intracellular PGE 2 was observed after the treatment with EEAH, suggesting that above-mentioned factors would determine PGE 2 regulation in biologic systems [ Table 2 ]. HaCaT cells were treated with EEAH and regulation of COX-1/2, MRP4, and PGT was evaluated using real-time PCR. Real-time PCR assay showed that EEAH increased expression level of COX-1/2, MRP4, and PGT [ Figure 1 ]. Observed data showed that high intracellular PGE 2 concentration in HaCaT cells may be due to the activation of COX-1 and 15-PGDH inhibition by EEAH.
Wound-healing effect of EEAH
In-vitro wound healing study was performed using HaCaT scratch model. Various experiment sets were designed to evaluate the results: no drug treatment as a negative control, TGF-β1 (100 pg/mL) as a positive control, EEAH (6.2 µg/mL) only and in combination with COX-1/2 inhibitor (SC 560 0.5µM and Celecoxib 0.5µM), respectively. The photographs were taken before treatment and after 2 days incubation at 37°C, 5% CO 2 . EEAH facilitated wound healing (recovery distance: 60%) as compared with the negative control (recovery distance: 15%). Woundhealing effect of EEAH was comparable with TGF-β1 (recovery distance 81%). Similarly, COX-1 inhibitor (SC560) prevented the would-healing effect of EEAH partially (recovery distance: 37%); however, COX-2 inhibitor (Celecoxib, recovery distance 40%) did not interfere with wound-healing effect of EEAH. These results suggested that COX pathway as supplier of PGE 2 plays important role in wound healing [ Figure 2 ]. During wound healing, we have also monitored elevation level of PGE 2 on time interval and higher PGE 2 concentration was observed during 12-24 h and slightly reduced at 48 hr [ Table 3 ]. In vitro wound-healing effect of EEAH in HaCaT cells. After scratch being made, immediately photographs were taken and widths were measured. Scratched cells were incubated for 2 days in 5% CO 2 incubator, the picture was again captured at the same place and widths were measured. Average width of wound was calculated with longest, medium and shortest length between the both cell populations. Control, no drug treatment; TGF-β1 (100 pg/mL), positive control; EEAH, ethanol extracts of Artocarpus heterophyllus (6.2 µg/mL); SC 560 (0.5 µM); C, Celecoxib (0.5 µM) [29] Previously, several scientists have reported wound-healing efficacy of plant extracts. [30] [31] [32] [33] This study investigated the role of PGE 2 during the wound-healing process that was induced by plant extract. Tissue regeneration plays important role during recovery from injury, including wound healing, and PGE 2 is candidate molecule that helps in regeneration of tissue. [34] After scratching, extracellular medium was collected on different time interval (0, 12, 24, and 48 h) and PGE 2 concentration was measured. When wound being, the activity of PGE 2 was increased because there was increase on extracellular PGE 2 concentration during 12 and 24 h in all the tested samples because of inflammatory and proliferative actions on wound bed. COX-2 expression and PGE 2 production in the wound bed increase as dermal wound healing transitions from scarless to a scarring phenotype. [12] At a cellular level, PGE 2 was shown to regulate the proliferation of fibroblasts from both wound-healing phenotypes. Hemostasis, inflammatory, proliferative, and remodeling are the major steps of wound healing, where PGE 2 plays an important role. [35] EEAH plays important role to elevate PGE 2 level in cellular system by inhibiting 15-PGDH that accelerates wound healing.
CONCLUSIONS
15-PGDH inhibitor alone will give better result of wound healing than COX inhibitors because of elevated level of PGE 2 . Therefore, inhibition of 15-PGDH with plant extracts will be valuable for the therapeutic management of diseases requiring elevated PGE 2 levels like in wound healing. The clinical efficacy and safety of these plant extracts as well as the purification of active ingredients from these plants remains to be done.
